Page 185 - Pagetit
P. 185

NEUROSCIENCE OF PSYCHOACTIVE SUBSTANCE USE AND DEPENDENCE



                   Sander T et al. (1999b) Association analysis of exonic variants of the gene encoding
                   the GABA(B) receptor and alcohol dependence. Psychiatric Genetics, 9:69–73.
                   Sander T et al. (2000) Genetic variation of the glutamate transporter EAAT2 gene
                   and vulnerability to alcohol dependence. Psychiatric Genetics, 10:103–107.
                   Sauer B (1998) Inducible gene targeting in mice using the Cre/lox system.
                   Methods, 14:381–392.
                   Schuckit MA (2000) Genetics of the risk for alcoholism. American Journal of the
                   Addictions, 9:103–112.
                   Schuckit MA et al. (1999) Selective genotyping for the role of 5-HT2A, 5-HT2C,
                   and GABA alpha6 receptors and the serotonin transporter in the level of response
                   to alcohol: a pilot study. Biological Psychiatry, 45:647–651.
                   Schmid H (2000) Protektive faktoren. [Protective factors.] In: Uchtenhagen A,
                   Zieglgänsberger W, eds. Suchtmedizin: konzepte, strategien und therapeutsches
                   management. [Addiction medicine: concepts, strategies and therapeutic
                   management.] Munich, Urban & Fischer Verlag:226–234.
                   Schmidt LG et al. (2000) Different allele distribution of a regulatory MAOA gene
                   promoter polymorphism in antisocial and anxious–depressive alcoholics. Journal
                   of Neural Transmission, 107:681–689.
                   Sellers EM, Tyndale RF (2000) Mimicking gene defects to treat drug dependence.
                   Annals of the New York Academy of Sciences, 909:233–246.
                   Sellers EM, Kaplan HL, Tyndale RF (2000) Inhibition of cytochrome P4502A6
                   increases nicotine’s oral bioavailability and decreases smoking.  Clinical
                   Pharmacology and Therapeutics, 68:35–43.

                   Sellers EM et al. (2002, in press) Inhibiting CYP2A6 decreases smoking and
                   increases the detoxification of the procarcinogen 4-(methylnitrosamino)-
                   (3-pyridyl)-1-butanone (NNK). Nicotine and Tobacco Research (in press).
                   Shea SH et al. (2001) ADH2 and alcohol-related phenotypes in Ashkenazic Jewish
                   American college students. Behavior Genetics, 31:231–239.
                   Shields PG et al. (1998) Dopamine D4 receptors and the risk of cigarette smoking
                   in African- Americans and Caucasians. Cancer Epidemiology and Biomarkers
                   Preview, 7:453–458.
                   Silverman MA et al. (2000) Haplotypes of four novel single nucleotide
                   polymorphisms in the nicotinic acetylcholine receptor beta2 subunit (CHRNB2)
                   gene show no association with smoking initiation or nicotine dependence.
                   American Journal of Medical Genetics, 96:646–653.
                   Singleton AB et al. (1998) Lack of association between the dopamine D2 receptor
                   gene allele DRD2*A1 and cigarette smoking in a United Kingdom population.
                   Pharmacogenetics, 8:125–128.
                   Slutske WS et al. (1999) The heritability of alcoholism symptoms: “indicators of
                   genetic and environmental influence in alcohol-dependent individuals” revisited.
                   Alcoholism: Clinical and Experimental Research, 23:759–769.
                   Spergel DJ et al. (2001) Using reporter genes to label selected neuronal
                   populations in transgenic mice for gene promoter, anatomical, and physiological
                   studies. Progress in Neurobiology, 63:673–686.


                                                  164




          Chapter_5                164                             19.1.2004, 11:46
   180   181   182   183   184   185   186   187   188   189   190